Study Evaluating the Safety of Enbrel (Etanercept)

NCT00683384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2010-11-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.

Conditions

  • Arthritis, Psoriatic

Interventions

DRUG

Etanercept (Enbrel)

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Philippines

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00683384 on ClinicalTrials.gov